Patient 21
Nicolas Hantzsch has had a successful career in C-level and management positions for various startups in Berlin, London, Chicago, NYC and San Francisco for the last 10+ years. Like his co-founder, he repeatedly successfully beat cancer in 2010 and 2015.
His greatest successes are Veganz (IPO), MetaTravel/HometoGo (IPO), Groupon (IPO). He is also co-founder of Oysterbay Venture Capital, which successfully invested in Oatly (IPO) at an early stage.
Patient 21
Patient 21 is a healthtech company that aims to empower patients and doctors to make better decisions by leveraging data.